TIM3 expression by leukemic and non-leukemic myeloblasts

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

(2012) M. K. Gleason et al.   BLOOD

Prospects for TIM3-Targeted Antitumor Immunotherapy

(2011) S. F. Ngiow et al.   CANCER RESEARCH

Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up

(2011) Hanne Ø. Larsen et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

TIM polymorphisms—genetics and function

(2011) J Lee et al.   GENES AND IMMUNITY

Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways

(2011) J. Lee et al.   MOLECULAR AND CELLULAR BIOLOGY

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker

(2011) M. Jan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signaling changes in the stem cell factor–AKT-S6 pathway in diagnostic AML samples are associated with disease relapse

(2011) S M Kornblau et al.   Blood Cancer Journal

Identification of CCL1 as a Gene Differentially Expressed in CD4+T Cells Expressing TIM-3

(2011) Ka Jung Jun et al.   Immune Network

TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

(2010) Yoshikane Kikushige et al.   Cell Stem Cell

Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis

(2010) Kazuki Sakai et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Blockade of CCL1 Inhibits T Regulatory Cell Suppressive Function Enhancing Tumor Immunity without Affecting T Effector Responses

(2010) D. B. Hoelzinger et al.   JOURNAL OF IMMUNOLOGY